Persistent antibodies to HPV virus-like particles following natural infection are protective against subsequent cervicovaginal infection with related and unrelated HPV.
about
Serological prevalence and persistence of high-risk human papillomavirus infection among women in Santiago, Chile.Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfectionReevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types.A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infectionThe impact of HPV female immunization in Italy: model based predictions.The known unknowns of HPV natural history.Population-based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women.Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global reviewNatural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis.Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women.Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16.Updating the natural history of human papillomavirus and anogenital cancersReview: current knowledge on the role of HPV antibodies after natural infection and vaccination: implications for monitoring an HPV vaccination programme.Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions.Impact of Serum Antibodies to HPV Serotypes 6, 11, 16, and 18 to Risks of Subsequent Genital HPV Infections in Men: The HIM Study.Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.Natural History of HPV Infection across the Lifespan: Role of Viral Latency.Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model.Aggregation and competitive exclusion: explaining the coexistence of human Papillomavirus types and the effectiveness of limited vaccine conferred cross-immunity.
P2860
Q33880956-75CE01AD-0177-4659-8239-40BB3F5313DCQ33947813-C721D16D-8D23-4A79-AA76-4FCC3D7FCD2CQ34370578-5E941847-5CFB-4738-B87C-5FF3EBAD8A80Q34593100-C067A596-BF63-4E11-8AD7-2B54895DE934Q34970731-F63A97E3-6790-4681-9B5A-B67E673126E1Q35117850-19E937A5-7A0B-47DB-85E8-3D6BA048B6CBQ35578583-BE8BDC37-A55D-4864-8B77-8B41EFC9AEE4Q35659008-4E06950C-52E0-4EE3-9658-D4B948F653A7Q36609068-40C67810-A26A-4334-B24E-EAD73807DE85Q36745242-304357CF-CA5F-4957-B7DE-C3998501C990Q36921606-E8017CD3-30FD-4E7B-BD01-119EDF874137Q36974917-75BD5CE2-A5E8-4457-97A0-A6883F00CDD8Q36979148-FEEC9403-BBB1-4374-A588-C5A30C34BF33Q38110696-8379C747-1A89-462D-9A70-D7F169BDACAFQ39122093-4696AD5C-AA7A-43E2-91E2-4708310A68FFQ40571982-CA7FB7C9-6A34-45C2-AE7A-36919EDFA2D6Q40603173-82582D83-5B18-416C-BB66-62B8E8D75D01Q41932990-858CC57A-00F8-4216-9453-72FAB2176F58Q42273331-82008248-DAD9-4E45-98B7-73ABC5BDB0FCQ51557810-C5393A62-9B53-46C2-A85B-C63ACFAC0DB8
P2860
Persistent antibodies to HPV virus-like particles following natural infection are protective against subsequent cervicovaginal infection with related and unrelated HPV.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Persistent antibodies to HPV v ...... ith related and unrelated HPV.
@ast
Persistent antibodies to HPV v ...... ith related and unrelated HPV.
@en
type
label
Persistent antibodies to HPV v ...... ith related and unrelated HPV.
@ast
Persistent antibodies to HPV v ...... ith related and unrelated HPV.
@en
prefLabel
Persistent antibodies to HPV v ...... ith related and unrelated HPV.
@ast
Persistent antibodies to HPV v ...... ith related and unrelated HPV.
@en
P2093
P2860
P356
P1433
P1476
Persistent antibodies to HPV v ...... ith related and unrelated HPV.
@en
P2093
Robert D Burk
Susan M Hailpern
Zainab A Malik
P2860
P304
P356
10.1089/VIM.2009.0055
P577
2009-12-01T00:00:00Z